(Reuters) - AstraZeneca has warned it could relocate its vaccine manufacturing site from the UK to the U.S. amid a deadlock in negotiations with the Labour government over plans to cut state aid promised to the project, the Financial Times reported on Thursday.
(Reporting by Urvi Dugar in Bengaluru; Editing by Arun Koyyur)